Hemab Therapeutics completes $346.7M IPO at $18/share, adopts anti-takeover defenses
Filed May 4, 2026 · Period ending May 4, 2026 · ~1 min read
5 material changes detected in this filing.
Create a free account to read the full summary — it takes 30 seconds.
Partner
Trade COAG commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Generated by AI · Jun 2, 2026 5:48 AM